ENDRA Life Sciences Inc. Appoints Alexander Tokman as Acting Chief Executive Officer and Adds Ziad Rouag as Head of Regulatory and Clinical Affairs and Richard Jacroux as Chief Financial Officer
Position
Head of Regulatory and Clinical Affairs
Company
ENDRA Life Sciences
Description
ENDRA Life Sciences Inc. announced the appointment of Alexander Tokman as acting Chief Executive Officer to replace Francois Michelon, who stepped down from his role as Chief Executive Officer and as a member of the Board of Directors. Additionally, the Company added Ziad Rouag as Head of Regulatory and Clinical Affairs and Richard Jacroux as Chief Financial Officer.
Quick answer
ENDRA Life Sciences Inc. Appoints Alexander Tokman as Acting Chief Executive Officer and Adds Ziad Rouag as Head of Regulatory and Clinical Affairs and Richard Jacroux as Chief Financial Officer (August 13, 2024). ENDRA Life Sciences is based in Ann Arbor, Michigan, United States.
- Who is the new Head of Regulatory and Clinical Affairs at ENDRA Life Sciences?
- ENDRA Life Sciences named Ziad Rouag Head of Regulatory and Clinical Affairs, announced August 13, 2024.
- What did ENDRA Life Sciences announce on August 13, 2024?
- ENDRA Life Sciences Inc. announced the appointment of Alexander Tokman as acting Chief Executive Officer to replace Francois Michelon, who stepped down from his role as Chief Executive Officer and as a member of the Board of Directors. Additionally, the Company added Ziad Rouag as Head of Regulatory and Clinical Affairs and Richard Jacroux as Chief Financial Officer.
- What does ENDRA Life Sciences do?
- ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care.
- Where is ENDRA Life Sciences based?
- ENDRA Life Sciences is based in Ann Arbor, Michigan, United States.
- Which similar companies made leadership changes around the same time?
- North Coast Medical (August 14, 2024), Amsel Medical Corporation (July 30, 2024), Tenon Medical (August 27, 2024) and Baxter International (September 4, 2024) also announced leadership changes within 45 days of ENDRA Life Sciences.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Medical Device
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Adam C. Buglio Joins North Coast Medical, Inc. as Chief Revenue Officer (CRO) (August 14, 2024)
- Amsel Medical Corporation Appoints James A. Heinz, MSL as Chief Executive Officer (July 30, 2024)
- Tenon Medical Appoints Kevin Williamson as Chief Financial Officer (August 27, 2024)
- Baxter International Inc. Names Joel Grade as Interim Chief Accounting Officer (September 4, 2024)
- Zimmer Biomet appoints David DeMartino as Senior Vice President, Investor Relations (September 5, 2024)
- Boston Scientific Appoints Dr. Angelo Auricchio as Chief Medical Officer of Rhythm Management Business in EMEA (September 11, 2024)
Who to call at ENDRA Life Sciences, and when
A new leader at ENDRA Life Sciences brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day ENDRA Life Sciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ENDRA Life Sciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ENDRA Life Sciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ENDRA Life Sciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ENDRA Life Sciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.